Kaleo Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 220

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 7

Kaleo General Information

Description

Manufacturer of pharmaceutical products intended to empower patients and families to live fuller, bolder lives. The company's products use drug delivery technology and offer epinephrine auto-injectors and focus on delivery molecules, biologics, biosimilars, human factors engineering, and vaccines, enabling doctors to confidently take control in potentially life-threatening situations.

Contact Information

Website
www.kaleo.com
Formerly Known As
Intelliject
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 111 Virginia Street
  • Suite 300
  • Richmond, VA 23219
  • United States
+1 (804)
Primary Industry
Drug Delivery
Corporate Office
  • 111 Virginia Street
  • Suite 300
  • Richmond, VA 23219
  • United States
+1 (804)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kaleo Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kaleo‘s full profile, request access.

Request a free trial

Kaleo Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical products intended to empower patients and families to live fuller, bolder lives. The comp
Drug Delivery
Richmond, VA
220 As of 2023

Baar, Switzerland
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kaleo Competitors (2)

One of Kaleo’s 2 competitors is Stallergenes Greer, a Private Equity-Backed company based in Baar, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Stallergenes Greer Private Equity-Backed Baar, Switzerland
Adamis Pharmaceuticals Corporation San Diego, CA
You’re viewing 2 of 2 competitors. Get the full list »

Kaleo Patents

Kaleo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1141123-S1 Retention structure for medicament delivery device Active 25-Oct-2024
WO-2026006286-A1 Devices and methods for delivering medicaments Pending 25-Jun-2024
WO-2024263566-A2 Dry powder compositions for rapid reconstitution and parenteral delivery Inactive 20-Jun-2023
WO-2024263566-A3 Dry powder compositions for rapid reconstitution and parenteral delivery Inactive 20-Jun-2023
US-20260315685-A1 Devices and methods for delivering reconstituted medicaments Pending 22-May-2023 A61M5/1409
To view Kaleo’s complete patent history, request access »

Kaleo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kaleo Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kaleo‘s full profile, request access.

Request a free trial

Kaleo FAQs

  • When was Kaleo founded?

    Kaleo was founded in 2004.

  • Where is Kaleo headquartered?

    Kaleo is headquartered in Richmond, VA.

  • What is the size of Kaleo?

    Kaleo has 220 total employees.

  • What industry is Kaleo in?

    Kaleo’s primary industry is Drug Delivery.

  • Is Kaleo a private or public company?

    Kaleo is a Private company.

  • What is the current valuation of Kaleo?

    The current valuation of Kaleo is .

  • What is Kaleo’s current revenue?

    The current revenue for Kaleo is .

  • How much funding has Kaleo raised over time?

    Kaleo has raised $195M.

  • Who are Kaleo’s investors?

    CVC Marathon and Princeton Biopharma Capital Partners have invested in Kaleo.

  • Who are Kaleo’s competitors?

    Stallergenes Greer and Adamis Pharmaceuticals are competitors of Kaleo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process